The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.

The Dallas-based specialty care platform, valued at $1 billion in 2023 and now rebranded as Lantern, has expanded its ...

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.

Federal regulators are accusing the country's three largest pharmacy benefit managers of illegally driving up the cost of ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The complaint targets the group purchasing organizations affiliated with the "big three" pharmacy benefit managers: CVS ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...